BeiGene (BGNE)
(Delayed Data from NSDQ)
$161.13 USD
-7.51 (-4.45%)
Updated May 10, 2024 04:00 PM ET
After-Market: $160.50 -0.63 (-0.39%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-2.18 | 0.34% |
Earnings Summary
For their last quarter, BeiGene (BGNE) reported earnings of -$2.41 per share, beating the Zacks Consensus Estimate of $-2.98 per share. This reflects a positive earnings surprise of 19.13%. Look out for BGNE's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$2.18 per share, reflecting a year-over-year increase of 40.11%.
Earnings History
Price & Consensus
Zacks News for BGNE
3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
BGNE: What are Zacks experts saying now?
Zacks Private Portfolio Services